Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-071196

Chief Executive Officer acquired 11,806 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-23 Exercise or conversion : show line 1 in the form +11,806 $5.19 $61,273 3,245,828 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-23 Exercise or conversion : show line 2 in the form Stock Option (right to buy Common Stock) −11,806 773,227 D
Loading xslF345X03/doc4.xml…